On the recordFebruary 24, 2016
I want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like Matt to actually get a drug and have the 'Right to Try.'
Source
congress.govI want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like Matt to actually get a drug and have the 'Right to Try.'
Ron Johnson emphasizes the need to focus on patient access to drugs, not just approval rates.
Share
More from Ron Johnson
There was a concern whether or not we could actually pass the budget resolution tonight.
That’s a 200,000-vote differential. That’s what ought to concern Tom Tiffany, and of course he’s not gonna run against Francesca Hong; he’s probably going to have a more formidable opponent.
I mean, fortunately, now we have Bobby Kennedy, I think gaining a little bit more control over the agency.
I can understand why the president of the United States doesn’t want the news outlets that are aiding and abetting our enemies into his workspace.